These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8851655)

  • 1. Issues in polypharmacotherapy: focus on depression in schizophrenia.
    Dufresne RL
    Psychopharmacol Bull; 1995; 31(4):789-96. PubMed ID: 8851655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a rational pharmacotherapy intervention for inpatients at a psychiatric department.
    Sorensen L; Nielsen B; Stage KB; Brøsen K; Damkier P
    Nord J Psychiatry; 2008; 62(3):242-9. PubMed ID: 18622885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy with neuroleptics and antidepressive agents: a fundamental and critical discussion from a biological viewpoint].
    Langer G
    Wien Klin Wochenschr; 1983 Jul; 95(14):474-8. PubMed ID: 6138904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance, evaluation, and management of secondary depression in schizophrenia.
    Becker RE; Singh MM; Meisler N; Shillcutt S
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):26-32. PubMed ID: 2865254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Depressive patients with delusions--diagnosis and pharmacotherapy in a difficult group with depression].
    Wolfersdorf M; König F
    Schweiz Rundsch Med Prax; 1994 Apr; 83(15):438-43. PubMed ID: 7910412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug combinations in the treatment of depression].
    des Lauriers A; Puech A; Allilaire JF
    Sem Hop; 1982 Nov; 58(42):2432-9. PubMed ID: 6130602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antidepressant treatment of schizophrenic patients].
    Caroli F; Baldacci-Epinette C; Ribeyre P
    Encephale; 1993 Jul; 19 Spec No 2():393-6. PubMed ID: 7904237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing treatment-resistant major depression.
    Nelson JC
    J Clin Psychiatry; 2003; 64 Suppl 1():5-12. PubMed ID: 12625799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial].
    Shiloh R; Weizman A; Weizer N; Dorfman-Etrog P; Munitz H
    Harefuah; 2001 May; 140(5):369-73, 456. PubMed ID: 11419053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of depressive syndromes on a sectorized basic psychiatric unit].
    Burger E; Finger I
    Psychiatr Neurol Med Psychol Beih; 1988; 41():38-9. PubMed ID: 2908253
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of atypical antipsychotics in refractory depression and anxiety.
    Nemeroff CB
    J Clin Psychiatry; 2005; 66 Suppl 8():13-21. PubMed ID: 16336032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polypharmacy in the treatment of schizophrenia].
    Messer T; Tiltscher C; Schmauss M
    Fortschr Neurol Psychiatr; 2006 Jul; 74(7):377-91. PubMed ID: 16804806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Maintenance and termination of drug therapy in psychiatry].
    Watanabe M
    Seishin Shinkeigaku Zasshi; 1999; 101(12):1018-23. PubMed ID: 10810606
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
    Mohamed S; Leslie DL; Rosenheck RA
    J Clin Psychiatry; 2009 Jun; 70(6):906-12. PubMed ID: 19422760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of neuroleptics on depressive symptoms].
    Tabeze JP
    Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.